Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
human homolog plays a role in anti-apoptosis. Zusätzlich bieten wir Ihnen PTMA Kits (21) und PTMA Proteine (21) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 89 products:
Prothymosin alpha-knockout mice showed an impaired long-term potentiation induction in the hippocampus along with decreased neurogenesis.
Prothymosin-alpha variants elicit anti-HIV-1 response via TLR4 (zeige TLR4 Antikörper) dependent and independent pathways.
These results demonstrate the clinical relevance of prothymosin alpha in regulating acetylation events during the pathogenesis of emphysema.
Only neurons possess the specific mechanisms required to release prothymosin-alpha following cerebral ischemic stress in vivo.
Regional distribution and cell type-specific subcellular localization of Prothymosin alpha in brain.
Thymosin alpha-1 could relieve radiation-induced acute and late pulmonary injuries.
observations suggest that Talpha1 can positively modulate the haematopoietic functions of normal murine bone marrow cells, in addition to its myelorestorative role in tumour-bearing mice showing suppressed myelopoiesis [thymosin alpha-1]
thymosin alpha 1, a naturally occurring thymic peptide, induces functional maturation and interleukin-12 production by fungus-pulsed DCs through the p38 mitogen-activated protein kinase (zeige MAPK14 Antikörper)/nuclear factor (NF)-kappaB (zeige NFKB1 Antikörper)-dependent pathway.
ProT (zeige SLC6A7 Antikörper) overexpression in the kidneys of homozygous transgenic mice induced a PKD (zeige PRKD1 Antikörper) phenotype, which included polycystic kidneys, elevated blood urea nitrogen (BUN), and lethality at about 10 days of age.
Keap1 (zeige KEAP1 Antikörper)-bound prothymosin alpha peptide possesses a hairpin conformation and binds to cytoplasmic repressor Keap1 (zeige KEAP1 Antikörper) at the bottom region of the beta-propeller domain; complex formation occurs as a consequence of their complementary electrostatic interactions.
PTMA is a potential novel therapeutic target for type 2 diabetes
disease-free survival and overall survival rates were significantly lower among colorectal cancer patients with PTMA- and TP53 (zeige TP53 Antikörper)-positive tumors
Data suggest that KEAP1 (kelch-like ECH-associated protein 1 (zeige KEAP1 Antikörper)) mutations (as those observed in lung cancer patients) affect conformation/folding/stability of KEAP1 (zeige KEAP1 Antikörper) and binding affinity for ligands PTMA and NRF2 (nuclear factor erythroid 2-like 2 (zeige NFE2L2 Antikörper)).
Data suggest that plasma thymosin-alpha1 (TA1 (zeige TAAR1 Antikörper)) and prothymosin-alpha (PTMA) level may be a biomarker for differentiating between renal cell carcinoma (zeige MOK Antikörper) (RCC (zeige XRCC1 Antikörper)) and urothelial carcinoma.
prothymosin-alpha expression is a determinant of disease progression in superficial bladder cancer
PTalpha (zeige PTCRA Antikörper) offers cardioprotection against ischemic injury by an Akt (zeige AKT1 Antikörper)-dependent mechanism.
The PTMA is one of miR-1 target genes which involve in miR-1 inducing apoptosis.
Findings suggest that the binding of prothymosin alpha (ProTalpha) and Neh2 (zeige NEIL2 Antikörper) to Keap1 (zeige KEAP1 Antikörper) occurs synergistically via preformed structural elements.
human homolog plays a role in anti-apoptosis
, prothymosin, alpha (gene sequence 28)
, prothymosin alpha
, gene sequence 28
, prothymosin alpha protein